Skip to main content
. 2021 Jun 14;12:692051. doi: 10.3389/fimmu.2021.692051

Table 2.

The demographics and clinical characteristic of I-ANMOSD and II-ANMOSD.

Characteristic ANMOSD patients
Ⅰ-ANMOSD Ⅱ-ANMOSD P Value
(n = 17) (n = 15)
Age at onset, mean (SD), years 35.5 (9.7) 37.2 (7.4) 0.633
Female, no. (%) 12 (70.6%) 12 (80.0%) 0.691
Duration, median (range), months 4 (1–36) 6 (232) 0.560
Number of attacks, median (range) 1 (1–3) 2 (1–3) 0.188
MRI lesion
 Spinal cord, no. (%) 7 (41.2%) 5 (33.3%) 0.737
 Optic nerve, no. (%) 5 (29.4%) 6 (40.0%) 0.712
 Brain, no. (%) 4 (23.5%) 3 (20.0%) >0.999
 others, no. (%) 1 (5.9%) 1 (6.7%) >0.999
EDSS score 3.5 (1.5-4.5) 7.0 (5.0-9.0) <0.001
SBP before MRI 125.1 ± 13.0 121.1 ± 13.1 0.390
DBP before MRI 75.7 ± 10.6 79.5 ± 11.4 0.340
SBP after MRI 121.6 ± 13.1 118.1 ± 14.2 0.480
DBP after MRI 78.2 ± 9.4 82.4 ± 15.0 0.343
HR before MRI 76.1 ± 10.4 71.8 ± 12.4 0.301
HR after MRI 77.1 ± 9.5 73.1 ± 11.8 0.291

DBP, diastolic blood pressure; EDSS, expanded disability status scale; HR, heart rate; I-NMOSD, neuromyelitis optica spectrum disorders (EDSS scale ≤ 4.5); II-NMOSD, neuromyelitis optica spectrum disorders (EDSS scale > 4.5); SBP, systolic blood pressure.